Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Romana Gerner

    TitlePostdoctoral Scholar
    SchoolUniversity of California, San Diego
    DepartmentPediatrics
    Address9500 Gilman Drive #0704
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Innsbruck Medical University, Innsbruck, AustriaPhD2017Infectious Diseases
      Fertility Unit & Stem cell research, Karolinska Institute, Stockholm, Sweden2012Stem Cell Research
      Innsbruck Medical University, Innsbruck, AustriaMD2011School of Medicine

      Collapse ORNG Applications 
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Tilg H, Adolph TE, Gerner R, Moschen AR. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell. 2018 Mar 19. PMID: 29657127.
        View in: PubMed
      2. Gerner R, Klepsch V, Macheiner S, Arnhard K, Adolph TE, Grander C, Wieser V, Pfister A, Moser P, Hermann-Kleiter N, Baier G, Oberacher H, Tilg H, Moschen AR. NAD metabolism fuels human and mouse intestinal inflammation. Gut. 2017 Sep 06. PMID: 28877980.
        View in: PubMed
      3. Klepsch V, Gerner R, Klepsch S, Olson WJ, Tilg H, Moschen AR, Baier G, Hermann-Kleiter N. Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis. Gut. 2017 Aug 04. PMID: 28779026.
        View in: PubMed
      4. Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner R, Pfister A, Enrich B, Ciocan D, Macheiner S, Mayr L, Drach M, Moser P, Moschen AR, Perlemuter G, Szabo G, Cassard AM, Tilg H. Recovery of ethanol-inducedAkkermansia muciniphiladepletion ameliorates alcoholic liver disease. Gut. 2017 May 26. PMID: 28550049.
        View in: PubMed
      5. Moschen AR, Adolph TE, Gerner R, Wieser V, Tilg H. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation. Trends Endocrinol Metab. 2017 05; 28(5):388-397. PMID: 28214071.
        View in: PubMed
      6. Gerner R, Feistritzer C, Moschen AR, Kircher B, Moser P, Tilg H, Nachbaur D. Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease: A Report of 2 Cases. Transplantation. 2016 Dec; 100(12):e158-e159. PMID: 27861298.
        View in: PubMed
      7. Moschen AR, Gerner R, Wang J, Klepsch V, Adolph TE, Reider SJ, Hackl H, Pfister A, Schilling J, Moser PL, Kempster SL, Swidsinski A, Orth Höller D, Weiss G, Baines JF, Kaser A, Tilg H. Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations. Cell Host Microbe. 2016 Apr 13; 19(4):455-69. PMID: 27078067.
        View in: PubMed
      8. Wieser V, Tymoszuk P, Adolph TE, Grander C, Grabherr F, Enrich B, Pfister A, Lichtmanegger L, Gerner R, Drach M, Moser P, Zoller H, Weiss G, Moschen AR, Theurl I, Tilg H. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease. J Hepatol. 2016 Apr; 64(4):872-80. PMID: 26682726.
        View in: PubMed
      9. Zhang H, Panula S, Petropoulos S, Edsgärd D, Busayavalasa K, Liu L, Li X, Risal S, Shen Y, Shao J, Liu M, Li S, Zhang D, Zhang X, Gerner R, Sheikhi M, Damdimopoulou P, Sandberg R, Douagi I, Gustafsson JÅ, Liu L, Lanner F, Hovatta O, Liu K. Adult human and mouse ovaries lack DDX4-expressing functional oogonial stem cells. Nat Med. 2015 Oct; 21(10):1116-8. PMID: 26444631.
        View in: PubMed
      10. Nairz M, Schroll A, Haschka D, Dichtl S, Sonnweber T, Theurl I, Theurl M, Lindner E, Demetz E, Aßhoff M, Bellmann-Weiler R, Müller R, Gerner R, Moschen AR, Baumgartner N, Moser PL, Talasz H, Tilg H, Fang FC, Weiss G. Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response. Eur J Immunol. 2015 Nov; 45(11):3073-86. PMID: 26332507.
        View in: PubMed
      11. Tancevski I, Nairz M, Duwensee K, Auer K, Schroll A, Heim C, Feistritzer C, Hoefer J, Gerner R, Moschen AR, Heller I, Pallweber P, Li X, Theurl M, Demetz E, Wolf AM, Wolf D, Eller P, Ritsch A, Weiss G. Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2. EMBO Mol Med. 2014 Jun; 6(6):810-20. PMID: 24755316.
        View in: PubMed
      12. Gerner R, Moschen AR, Tilg H. Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trials. Dig Dis. 2013; 31(3-4):328-35. PMID: 24246983.
        View in: PubMed
      13. Wieser V, Gerner R, Moschen AR, Tilg H. Liver complications in inflammatory bowel diseases. Dig Dis. 2013; 31(2):233-8. PMID: 24030232.
        View in: PubMed
      14. Moschen AR, Wieser V, Gerner R, Bichler A, Enrich B, Moser P, Ebenbichler CF, Kaser S, Tilg H. Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. J Hepatol. 2013 Dec; 59(6):1315-22. PMID: 23928404.
        View in: PubMed
      15. Gerner R, Wieser V, Moschen AR, Tilg H. Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver. Can J Physiol Pharmacol. 2013 Nov; 91(11):867-72. PMID: 24117253.
        View in: PubMed
      16. Moschen AR, Gerner R, Schroll A, Fritz T, Kaser A, Tilg H. A key role for Pre-B cell colony-enhancing factor in experimental hepatitis. Hepatology. 2011 Aug; 54(2):675-86. PMID: 21567435.
        View in: PubMed
      17. Moschen AR, Gerner R, Tilg H. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des. 2010 Jun; 16(17):1913-20. PMID: 20370672.
        View in: PubMed
      18. Moschen AR, Geiger S, Gerner R, Tilg H. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat Res. 2010 Aug 07; 690(1-2):95-101. PMID: 19583971.
        View in: PubMed